Alternative Treatments?
Posted , 7 users are following.
Hi everybody! I'm really glad everyone is so welcoming here. I'm a
grandmother suffering from Raynaud's disease. My symptoms have
worsened as I have aged. I often have attacks that can last hours. In
the wintertime, sometimes it's every day. I don't make very much
money, and I am not old enough to get medicare. I have tried every
homeopathic cure, and nothing has helped. I am afraid I may need an
amputation in the future if something doesn't change. I have read a
few articles about using generic Viagra to treat Raynaud's symptoms,
and I was wondering if anyone has had any experience with this. My
primary care doctor is hesitant to prescribe it, as it's an off-label
use of the drug, but I am desperate! If anyone has experience with
this treatment, please reply or message me with any side effects you
experienced, and of course whether it worked! Thank you so much for
any help, this is a difficult thing to live with, and I feel better
knowing I'm not the only one.
0 likes, 8 replies
jenny pearlbeth
Posted
tim24983 pearlbeth
Posted
adrihay pearlbeth
Posted
sue73 adrihay
Posted
adrihay sue73
Posted
sue73 adrihay
Posted
gee013 pearlbeth
Posted
Phosphodiesterase type 5 inhibitors — In patients who have obtained some but inadequate benefit from a CCB and who tolerate that therapy, we suggest the addition of a PDE type 5 inhibitor and continue the CCB. In patients who do not benefit from the CCB, we either add a PDE inhibitor or try the PDE inhibitor as an alternative, depending upon the ability to tolerate the medications, if critical ischemia is not present. (See 'Severe symptoms despite oral and topical agents' below.)
Based upon the available evidence and our clinical experience, we initiate therapy at a low dose (eg, sildenafil 20 mg once or twice daily) and increase the dose to 20 mg three times daily if no benefit is achieved. This dose is similar to that used in patients with pulmonary hypertension. A four- to six-week trial should be adequate to determine whether the combination is of benefit. (See "Pulmonary vascular disease in systemic sclerosis (scleroderma): Treatment", section on 'Phosphodiesterase type 5 inhibitors'.)
Care must be taken to fully assess cardiopulmonary status (eg, for pulmonary hypertension) before starting combined vasodilation therapy. Systemic blood pressure measurements should be followed serially. When possible, we advise patients to obtain a blood pressure (BP) cuff and to monitor their BP daily at first until dosing is stable and then weekly thereafter, as well as when symptoms of hypotension occur.
A PDE inhibitor should not be used together with topical nitrates due to the increased risk of hypotension. Other adverse effects that may occur include peripheral edema, palpitations, tachycardia, hearing loss, and visual disturbances.
The increasing use of these medications in efforts to improve peripheral and pulmonary circulation in several disorders is discussed in separately. (See "Pulmonary vascular disease in systemic sclerosis (scleroderma): Treatment", section on 'Phosphodiesterase type 5 inhibitors' and "Treatment of idiopathic pulmonary fibrosis", section on 'Phosphodiesterase inhibitors'.)
Efficacy of PDE inhibition — The efficacy of sildenafil, tadalafil, and vardenafil was best examined in a meta-analysis of six randomized controlled trials that included 244 patients with secondary RP [1]. There was a modest but significant benefit of PDE inhibitors on Raynaud’s Condition Score (RCS), as well as on the frequency and duration of RP attacks [1]. PDE inhibitors reduced the frequency of RP attacks by approximately 0.5/day compared with placebo, which is comparable to the reduction reported in another meta-analysis assessing the efficacy of CCBs in systemic sclerosis (SSc)-related RP (0.6/day) [2]. The RCS represents the level of difficulty experienced by the patient each day that is attributed to RP, and is assessed using a visual analog scale. Although the improvement in the RCS was significant, it was not a clinically meaningful difference [3] (see "Initial treatment of the Raynaud phenomenon", section on 'Assessment of the response to therapy') Additional well-designed trials involving more patients are needed to better assess the role and optimal dosing of sildenafil, tadalafil, vardenafil, and other PDE inhibitors in primary and secondary RP.
sorry it is so long, and technical
gary
mary_alice07882 pearlbeth
Posted
For sore fingers, expose them to direct sunlight maybe 10 minutes a day.
Mary Alice 07882